메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
This study was conducted to evaluate the overall efficacy and safety of atypical antipsychotics (risperidone vs. olanzapine) in the treatment of inpatients with bipolar I disorder in Korea. Ninety six consecutive inpatients with bipolar I disorder at St. Mary’s Hospital in Seoul, Korea, were given olanzapine or risperidone as adjuncts to mood stabilizers for at least 1 month, in the absence of other antipsychotics. Details of the adverse effects, tolerability, and efficacy were reviewed on the basis of the treatment records on admission and after 4 weeks of hospitalization. The overall results showed that the two atypical antipsychotics had equivalent efficacies based on the Clinical Global Impression (CGI) and Global Assessment Functioning(GAF) scores. The frequencies of the extrapyramidal symptom-related side effects were higher in the risperidone-treated group than in the olanzapine-treated group. This small study suggests that the efficacies of risperidone and olanzapine are similar in inpatients with bipolar I disorder in a naturalistic setting and that the present data from a North-East Asian setting replicated and extended the findings of previous Western studies.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0